Total planned funding: $13,355,762
Allocations
Countries/Regions
Central Asia Region | $13,355,762 |
Organizational Types
Own Agency | $13,355,762 |
Program Areas
Management and Operations | $9,356,029 |
Governance and Systems | $1,293,854 |
Prevention | $1,229,266 |
Care | $557,988 |
Treatment | $466,417 |
Testing | $452,208 |
Budget Codes
HVMS: Management and Operations | $9,356,029 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $986,943 |
HLAB: Laboratory Infrastructure | $527,342 |
HVSI: Strategic Information | $487,910 |
HTXS: Treatment: Adult Treatment | $466,417 |
HVCT: Testing: HIV Testing and Counseling | $452,208 |
HBHC: Care: Adult Care and Support | $418,427 |
OHSS: Health Systems Strengthening | $278,602 |
HVOP: Sexual Prevention: Other Sexual Prevention | $161,418 |
HVTB: Care: TB/HIV | $139,561 |
HMBL: Biomedical Prevention: Blood Safety | $80,905 |
Top Partner Programs
USG Aggregated Agencies:
$13,355,762
Countries/Regions
Central Asia Region
2010 | $3,180,975 |
2012 | $1,121,824 |
2015 | $4,926,674 |
2016 | $4,126,289 |